126 related articles for article (PubMed ID: 2466094)
1. Tumour markers and POMB/ACE chemotherapy in the management of ovarian germ cell tumours (GCTs).
Newlands ES; Holden L; Bagshawe KD
Int J Biol Markers; 1988; 3(3):185-92. PubMed ID: 2466094
[TBL] [Abstract][Full Text] [Related]
2. Current optimum management of anaplastic germ cell tumours of the testis and other sites.
Newlands ES; Bagshawe KD; Begent RH; Rustin GJ; Crawford SM; Holden L
Br J Urol; 1986 Jun; 58(3):307-14. PubMed ID: 2424538
[TBL] [Abstract][Full Text] [Related]
3. The effect of intensity of administered treatment on the outcome of germ cell tumours treated with POMB/ACE chemotherapy.
Crawford SM; Newlands ES; Begent RH; Rustin GJ; Bagshawe KD
Br J Cancer; 1989 Feb; 59(2):243-6. PubMed ID: 2467683
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome in patients with germ cell tumours treated with POMB/ACE chemotherapy: comparison of commonly used classification systems of good and poor prognosis.
Hitchins RN; Newlands ES; Smith DB; Begent RH; Rustin GJ; Bagshawe KD
Br J Cancer; 1989 Feb; 59(2):236-42. PubMed ID: 2467682
[TBL] [Abstract][Full Text] [Related]
5. Treatment of patients with poor prognosis anaplastic germ cell tumours (AGCT) of the testis and other sites.
Newlands ES; Bagshawe KD; Begent RH; Rustin GJ; Crawford SM; Holden L
Int J Androl; 1987 Feb; 10(1):301-9. PubMed ID: 2438223
[TBL] [Abstract][Full Text] [Related]
6. VP-16 in combinations for first-line treatment of malignant germ-cell tumors and gestational choriocarcinoma.
Newlands ES
Semin Oncol; 1985 Mar; 12(1 Suppl 2):37-41. PubMed ID: 2579442
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy for poor risk germ cell tumours. An independent evaluation of the POMB/ACE regime.
Cullen MH; Harper PG; Woodroffe CM; Kirkbride P; Clarke J
Br J Urol; 1988 Nov; 62(5):454-60. PubMed ID: 2463034
[TBL] [Abstract][Full Text] [Related]
8. The UK Children's Cancer Study Group: testicular malignant germ cell tumours 1979-1988.
Huddart SN; Mann JR; Gornall P; Pearson D; Barrett A; Raafat F; Barnes JM; Wallendsus KR
J Pediatr Surg; 1990 Apr; 25(4):406-10. PubMed ID: 1691781
[TBL] [Abstract][Full Text] [Related]
9. Fertility after chemotherapy for male and female germ cell tumours.
Rustin GJ; Pektasides D; Bagshawe KD; Newlands ES; Begent RH
Int J Androl; 1987 Feb; 10(1):389-92. PubMed ID: 2438231
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis and treatment of germ cell tumors of the ovary].
Sawada M; Matsui Y; Okudaira Y
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2489-95. PubMed ID: 6210050
[TBL] [Abstract][Full Text] [Related]
11. Germ cell tumors in children: gonadal and extragonadal.
Wollner N; Ghavimi F; Wachtel A; Luks E; Exelby P; Woodruff J
Med Pediatr Oncol; 1991; 19(4):228-39. PubMed ID: 1711647
[TBL] [Abstract][Full Text] [Related]
12. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
Fizazi K; Prow DM; Do KA; Wang X; Finn L; Kim J; Daliani D; Papandreou CN; Tu SM; Millikan RE; Pagliaro LC; Logothetis CJ; Amato RJ
Br J Cancer; 2002 May; 86(10):1555-60. PubMed ID: 12085204
[TBL] [Abstract][Full Text] [Related]
13. Successful management of metastatic and primary germ cell tumors in the brain.
Rustin GJ; Newlands ES; Bagshawe KD; Begent RH; Crawford SM
Cancer; 1986 Jun; 57(11):2108-13. PubMed ID: 2421864
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy for ovarian germ cell tumours.
Bower M; Fife K; Holden L; Paradinas FJ; Rustin GJ; Newlands ES
Eur J Cancer; 1996 Apr; 32A(4):593-7. PubMed ID: 8695258
[TBL] [Abstract][Full Text] [Related]
15. Intensive induction chemotherapy for poor risk non-seminomatous germ cell tumours.
Horwich A; Brada M; Nicholls J; Jay G; Hendry WF; Dearnaley D; Peckham MJ
Eur J Cancer Clin Oncol; 1989 Feb; 25(2):177-84. PubMed ID: 2467806
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of markers AFP, HCG and LDH in advanced germ cell tumors before and after cytostasis resp.
Jaeger N; Vahlensieck W
Prog Clin Biol Res; 1985; 203():107-16. PubMed ID: 2421323
[No Abstract] [Full Text] [Related]
17. Malignant ovarian germ cell tumors: the experience at the Hospital de la Santa Creu i Sant Pau.
Germá JR; Izquierdo MA; Seguí MA; Climent MA; Ojeda B; Alonso C
Gynecol Oncol; 1992 May; 45(2):153-9. PubMed ID: 1375576
[TBL] [Abstract][Full Text] [Related]
18. Is ectopic production of human chorionic gonadotrophin (hCG) or alpha fetoprotein (AFP) by tumours a marker of chemosensitivity?
Crawford SM; Ledermann JA; Turkie W; Rustin GJ; Begent RH; Newlands ES; Bagshawe KD
Eur J Cancer Clin Oncol; 1986 Dec; 22(12):1483-7. PubMed ID: 2439342
[TBL] [Abstract][Full Text] [Related]
19. Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies.
Mann JR; Pearson D; Barrett A; Raafat F; Barnes JM; Wallendszus KR
Cancer; 1989 May; 63(9):1657-67. PubMed ID: 2467734
[TBL] [Abstract][Full Text] [Related]
20. Studies of the Australasian Germ Cell Trial Group: the management of advanced testis cancer.
Raghavan D; Levi J; Thomson D; Harvey V
Prog Clin Biol Res; 1990; 350():319-29. PubMed ID: 1696742
[No Abstract] [Full Text] [Related]
[Next] [New Search]
